(2-Methyl-1,3-benzoxazol-6-yl)boronic acid is an organoboron compound featuring a benzoxazole heterocyclic core substituted with a boronic acid functional group at the 6-position. It serves as a key synthetic intermediate, particularly in Suzuki-Miyaura cross-coupling reactions, which are pivotal for constructing biaryl and heterobiaryl systems in medicinal chemistry. Its primary application is in the research and development of pharmaceutical agents. The benzoxazole scaffold is a privileged structure in drug discovery, associated with a wide range of biological activities. This specific boronic acid derivative is utilized as a building block for synthesizing potential drug candidates, including kinase inhibitors and other small molecule therapeutics targeting various diseases. As a specialized boronic acid, it is a valuable reagent for introducing the 2-methylbenzoxazole moiety into more complex molecular architectures. It is typically handled under inert atmosphere conditions to preserve the reactivity of the boronic acid group and is used in research-scale organic synthesis.